Bioethics (BOTH) 10-Q 19 Aug 24 2024 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Jun. 30, 2024	Aug. 19, 2024
Cover [Abstract]
Entity Registrant Name	BIOETHICS, LTD.
Entity Central Index Key	0000894560
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Small Business	true
Entity Shell Company	true
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Document Period End Date	Jun. 30, 2024
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2024
Entity Common Stock Shares Outstanding		1,135,194
Entity File Number	33-55254-41
Entity Incorporation State Country Code	NV
Entity Tax Identification Number	87-0485312
Entity Address Address Line 1	1661 Lakeview Circle
Entity Address City Or Town	Ogden
Entity Address State Or Province	UT
Entity Address Postal Zip Code	84403
City Area Code	801
Local Phone Number	399-3632
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Jun. 30, 2024	Dec. 31, 2023
CURRENT ASSETS
Cash and cash equivalents	$ 10,168	$ 138
Total Current Assets	10,168	138
TOTAL ASSETS	10,168	138
CURRENT LIABILITIES
Accounts payable	150,679	122,400
Accounts payable - related party	2,500	14,500
Accrued interest - related parties	108,268	98,406
Accrued interest	108,887	98,363
Convertible notes payable	35,000	35,000
Notes payable	190,000	160,000
Notes payable - related parties	266,684	247,734
Total Current Liabilities	862,018	776,403
TOTAL LIABILITIES	862,018	776,403
STOCKHOLDERS' DEFICIT
Preferred stock, $0.01 par value; 25,000,000 shares authorized, -0- shares issued and outstanding	0	0
Common stock, $0.001 par value; 250,000,000 shares authorized, 1,135,194 shares issued and outstanding	1,135	1,135
Additional paid-in capital	500,479	500,479
Accumulated deficit	(1,353,464)	(1,277,879)
Total Stockholders' Deficit	(851,850)	(776,265)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 10,168	$ 138

Condensed Balance Sheets Parent

Condensed Balance Sheets Parenthetical - $ / shares	Jun. 30, 2024	Dec. 31, 2023
Condensed Balance Sheets
Preferred Stock, Par or Stated Value Per Share	$ 0.01	$ 0.01
Preferred Stock, Shares Authorized	25,000,000	25,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized	250,000,000	250,000,000
Common Stock, Shares, Issued	1,135,194	1,135,194
Common Stock, Shares, Outstanding	1,135,194	1,135,194

Condensed Statements of Operati

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Condensed Statements of Operations (Unaudited)
NET REVENUES	$ 0	$ 0	$ 0	$ 0
OPERATING EXPENSES
General and administrative	22,979	14,812	50,200	26,839
Total Operating Expenses	22,979	14,812	50,200	26,839
LOSS FROM OPERATIONS	(22,979)	(14,812)	(50,200)	(26,839)
OTHER INCOME (EXPENSES)
Interest expense	(12,953)	(11,998)	(25,385)	(23,607)
Total Other Income (Expenses)	(12,953)	(11,998)	(25,385)	(23,607)
NET LOSS BEFORE INCOME TAXES	(35,932)	(26,810)	(75,585)	(50,446)
PROVISION FOR INCOME TAXES	0	0	0	0
NET LOSS	$ (35,932)	$ (26,810)	$ (75,585)	$ (50,446)
BASIC AND DILUTED LOSS PER SHARE	$ (0.03)	$ (0.02)	$ (0.07)	$ (0.04)
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING	1,135,194	1,135,194	1,135,194	1,135,194

Condensed Statements of Stockho

Condensed Statements of Stockholders Deficit (Unaudited) - USD ($)	Total	Common Stock	Additional Paid-In Capital	Retained Earnings (Accumulated Deficit)
Balance, shares at Dec. 31, 2022		1,135,914
Balance, amount at Dec. 31, 2022	$ (679,116)	$ 1,135	$ 500,479	$ (1,180,730)
Net Income (Loss)	(23,636)	$ 0	0	(23,636)
Balance, shares at Mar. 31, 2023		1,135,914
Balance, amount at Mar. 31, 2023	(702,752)	$ 1,135	500,479	(1,204,366)
Balance, shares at Dec. 31, 2022		1,135,914
Balance, amount at Dec. 31, 2022	(679,116)	$ 1,135	500,479	(1,180,730)
Net Income (Loss)	(50,446)
Balance, shares at Jun. 30, 2023		1,135,914
Balance, amount at Jun. 30, 2023	(729,562)	$ 1,135	500,479	(1,231,176)
Balance, shares at Mar. 31, 2023		1,135,914
Balance, amount at Mar. 31, 2023	(702,752)	$ 1,135	500,479	(1,204,366)
Net Income (Loss)	(26,810)	$ 0	0	(26,810)
Balance, shares at Jun. 30, 2023		1,135,914
Balance, amount at Jun. 30, 2023	(729,562)	$ 1,135	500,479	(1,231,176)
Balance, shares at Dec. 31, 2023		1,135,914
Balance, amount at Dec. 31, 2023	(776,265)	$ 1,135	500,479	(1,277,879)
Net Income (Loss)	(39,653)	$ 0	0	(39,653)
Balance, shares at Mar. 31, 2024		1,135,914
Balance, amount at Mar. 31, 2024	(815,918)	$ 1,135	500,479	(1,317,532)
Balance, shares at Dec. 31, 2023		1,135,914
Balance, amount at Dec. 31, 2023	(776,265)	$ 1,135	500,479	(1,277,879)
Net Income (Loss)	(75,585)
Balance, shares at Jun. 30, 2024		1,135,914
Balance, amount at Jun. 30, 2024	(851,850)	$ 1,135	500,479	(1,353,464)
Balance, shares at Mar. 31, 2024		1,135,914
Balance, amount at Mar. 31, 2024	(815,918)	$ 1,135	500,479	(1,317,532)
Net Income (Loss)	(35,932)	$ 0	0	(35,932)
Balance, shares at Jun. 30, 2024		1,135,914
Balance, amount at Jun. 30, 2024	$ (851,850)	$ 1,135	$ 500,479	$ (1,353,464)

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (75,585)	$ (50,446)
Changes in operating assets and liabilities:
Accounts payable	28,279	11,417
Accounts payable - related party	(12,000)	3,000
Accrued interest - related parties	9,862	13,293
Accrued interest	10,524	10,314
Net Cash Used by Operating Activities	(38,920)	(12,422)
CASH FLOWS FROM INVESTING ACTIVITIES	0	0
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from notes payable	30,000	0
Proceeds from notes payable - related parties	18,950	12,600
Net Cash Provided by Financing Activities	48,950	12,600
INCREASE IN CASH AND CASH EQUIVALENTS	10,030	178
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	138	295
CASH AND CASH EQUIVALENTS AT END OF PERIOD	10,168	473
SUPPLEMENTAL DISCLOSURES:
Cash paid for interest	5,000	0
Cash paid for income taxes	$ 0	$ 0

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	Jun. 30, 2024
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 1 ‑ SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Organization - Bioethics, Ltd. (“the Company”) was organized under the laws of the State of Nevada on July 26, 1990. The Company was organized to provide a vehicle for participating in potentially profitable business ventures which may become available through the personal contacts of and at the complete discretion of the Company’s officers and directors. The Company has not paid any dividends and any dividends that may be paid in the future will depend upon the financial requirements of the Company and other relevant factors. The accompanying financial statements are condensed and have been prepared by the Company without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations, and cash flows for the six months ended June 30, 2024 and 2023 have been made. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these financial statements be read in conjunction with the financial statements and notes thereto included in the Company’s December 31, 2023 audited financial statements. The results of operations for the six months ended June 30, 2024 are not necessarily indicative of the operating results for the full year.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	6 Months Ended
	Jun. 30, 2024
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS	NOTE 2 ‑ RELATED PARTY TRANSACTIONS Management Compensation - During the six months ended June 30, 2024 and 2023, the Company did not pay any compensation to its officers and directors. Beginning August 2017, the Company entered into an oral agreement to pay the Company’s President $500 per month as payment for use of his personal residence as the Company’s office and mailing address. The Company has recorded rent expense of $3,000 during each of the six months ended June 30, 2024 and 2023, which is included in the general and administrative expenses on the statements of operations. The amount payable at December 31, 2023 was $14,500. During the six months ended June 30, 2024, the Company paid 15,000, resulting in $2,500 payable at June 30, 2024. On March 8, 2018, the Company entered into a promissory note with a newly-affiliated party in the amount of $43,250. The note is payable on demand and carries interest at 10% per annum. Interest expense for the six months ended June 30, 2024 and 2023 was $2,151 and $2,145, respectively, resulting in accrued interest of $27,307 and $25,156 at June 30, 2024 and December 31, 2023, respectively. Principal balance on the note at June 30, 2024 and December 31, 2023 was $43,250. On December 12, 2017, the Company entered into a promissory note with its President in the amount of $107,000. On various dates from the origin of the note through December 31, 2023, the officer advanced the Company an additional $118,170, and the Company made payments of $20,686, resulting in the total note principal balance of $204,484 at December 31, 2023. During the six months ended June 30, 2024 and 2023, the Company received an additional $18,950 and $12,600, respectively, and did not make any repayments of the principal balance resulting in the total note principal balance of $223,434 at June 30, 2024. The cumulative note balance is uncollateralized, due on demand, and carries interest at 12% per annum. Interest expense on the note for the six months ended June 30, 2024 and 2023 was $12,711 and $11,148, respectively, of which the Company repaid $5,000 during the six months ended June 30, 2024, resulting in accrued interest totaling $80,961 and $73,250 at June 30, 2024 and December 31, 2023, respectively.

NOTES PAYABLE

NOTES PAYABLE	6 Months Ended
	Jun. 30, 2024
NOTES PAYABLE
NOTES PAYABLE	NOTE 3 - NOTES PAYABLE On June 14, 2016, the Company issued a promissory note in the principal amount of $35,000 to an unaffiliated lender. The Note is due on demand at any time after its original maturity date of June 14, 2017, and carries an interest rate of 8% per annum. Interest expense for the six months ended June 30, 2024 and 2023 totaled $1,392 and $1,388, respectively, resulting in accrued interest at June 30, 2024 and December 31, 2023 of $22,534 and $21,142, respectively. Principal balance due on the note at June 30, 2024 and December 31, 2023 was $35,000. On August 15, 2018, the Company issued a promissory note in the principal amount of $10,000 to an unaffiliated lender. The Note was due on November 15, 2018, is currently in default, and carries an interest rate of 12% per annum. Interest expense for the six months ended June 30, 2024 and 2023 totaled $597 and $595, respectively, resulting in accrued interest at June 30, 2024 and December 31, 2023 of $6,304 and $5,707, respectively. Principal balance on the note at June 30, 2024 and December 31, 2023 was $10,000. On November 15, 2018, the Company issued a promissory note in the principal amount of $20,000 to an unaffiliated lender. The Note was due on February 15, 2019, is currently in default, and carries an interest rate of 12% per annum. Interest expense for the six months ended June 30, 2024 and 2023 totaled $1,193 and $1,190, respectively, resulting in accrued interest at June 30, 2024 and December 31, 2023 of $12,608 and $11,415, respectively. Principal balance on the note at June 30, 2024 and December 31, 2023 was $20,000. On December 31, 2018, the Company issued a promissory note in the principal amount of $30,000 to an unaffiliated lender. The Note was due on December 31, 2019, is currently in default, and carries an interest rate of 12% per annum. Interest expense for the six months ended June 30, 2024 and 2023 totaled $1,790 and $1,785, respectively, resulting in accrued interest at June 30, 2024 and December 31, 2023 of $18,912 and $17,122, respectively. Principal balance on the note at June 30, 2024 and December 31, 2023 was $30,000. On January 23, 2019, the Company issued a promissory note in the principal amount of $50,000 to an unaffiliated lender. The Note was due on January 23, 2022, is currently in default, and carries an interest rate of 12% per annum. Interest expense for the six months ended June 30, 2024 and 2023 totaled $2,984 and $2,975, respectively, resulting in accrued interest at June 30, 2024and December 31, 2023 of $31,521 and $28,537, respectively. Principal balance on the note at June 30, 2024 and December 31, 2023 was $50,000. On May 1, 2020, the Company issued a promissory note in the principal amount of $5,000 to an unaffiliated lender. The Note was due on May 1, 2022 and is now due on demand and carries an interest rate of 12% per annum. Interest expense for the six months ended June 30, 2024 and 2023 totaled $298 and $298, respectively, resulting in accrued interest at June 30, 2024 and December 31, 2023 of $2,490 and $2,191, respectively. Principal balance on the note at June 30, 2024 and December 31, 2023 was $5,000. On April 18, 2022, the Company issued a promissory note in the principal amount of $10,000 to an unaffiliated lender. The Note was due on April 18, 2023 and is now due on demand and carries an interest rate of 8% per annum. Interest expense for the six months ended June 30, 2024 and 2023 totaled $398 and $397, respectively, resulting in accrued interest at June 30, 2024 and December 31, 2023 of $1,761 and $1,363, respectively. Principal balance on the note at June 30, 2024 and December 31, 2023 was $10,000. On May 9, 2024, the Company issued a promissory note in the principal amount of $10,000 to an unaffiliated lender. The Note is due on May 9, 2025 and carries an interest rate of 10% per annum. Interest expense for the six months ended June 30, 2024 and 2023 totaled $142 and $-0-, respectively, resulting in accrued interest at June 30, 2024 and December 31, 2023 of $142 and $-0-, respectively. Principal balance on the note at June 30, 2024 and December 31, 2023 was $10,000. On June 21, 2024, the Company issued a promissory note in the principal amount of $10,000 to an unaffiliated lender. The Note is due on June 21, 2025 and carries an interest rate of 10% per annum. Interest expense for the six months ended June 30, 2024 and 2023 totaled $25 and $-0-, respectively, resulting in accrued interest at June 30, 2024 and December 31, 2023 of $25 and $-0-, respectively. Principal balance on the note at June 30, 2024 and December 31, 2023 was $10,000. On June 25, 2024, the Company issued a promissory note in the principal amount of $10,000 to an unaffiliated lender. The Note is due on June 25, 2025 and carries an interest rate of 10% per annum. Interest expense for the six months ended June 30, 2024 and 2023 totaled $14 and $-0-, respectively, resulting in accrued interest at June 30, 2024 and December 31, 2023 of $14 and $-0-, respectively. Principal balance on the note at June 30, 2024 and December 31, 2023 was $10,000.

CONVERTIBLE NOTES PAYABLE

CONVERTIBLE NOTES PAYABLE	6 Months Ended
	Jun. 30, 2024
CONVERTIBLE NOTES PAYABLE
CONVERTIBLE NOTES PAYABLE	NOTE 4 – CONVERTIBLE NOTES PAYABLE On December 18, 2019, the Company issued a convertible promissory note in the original principal amount of $10,000 to a lender. The Note was due on June 18, 2020, is currently in default, and carries an interest rate of 8% per annum. The Note is due and payable in full unless converted partially or in its entirety upon the election of the lender into fully paid and non-assessable shares of common stock of the Company at a conversion rate of $2.00 per share. The Company recognized a beneficial conversion feature and recorded a debt discount in the amount of $4,000, which was amortized over the life of the promissory note. At June 30, 2024 and December 31, 2023, the unamortized debt discount was $-0-, and the net convertible note balance was $10,000. The amortization of debt discount was $- 0- during the six months ended June 30, 2024 and June 30, 2023. Interest expense for the six months ended June 30, 2024 and 2023totaled $597 and $595, respectively, resulting in accrued interest at June 30, 2024 and December 31, 2023 of $3,827 and $3,231, respectively. Principal balance on the note at June 30, 2024and December 31, 2023 was $10,000. On June 9, 2020, the Company issued a convertible promissory note in the original principal amount of $10,000 to a lender. The Note was due on June 9, 2021, is currently in default, and carries an interest rate of 10% per annum. The Note is due and payable in full unless converted partially or in its entirety upon the election of the lender into fully paid and non-assessable shares of common stock of the Company at a conversion rate of $2.50 per share. The Company recognized a beneficial conversion feature and recorded a debt discount in the amount of $6,200, which was amortized over the life of the promissory note. At June 30, 2024 and December 31, 2023, the unamortized debt discount was $- 0, and the net convertible note balance was $10,000. The amortization of debt discount was $- 0- during the six months ended June 30, 2024 and 2023, respectively. Interest expense for the six months ended June 30, 2024 and 2023 totaled $497 and $496, respectively, resulting in accrued interest at June 30, 2024 and December 31, 2023 of $4,059 and $3,562. Principal balance on the note at June 30, 2024 and December 31, 2023 was $10,000. On August 3, 2020, the Company issued a convertible promissory note in the original principal amount of $15,000 to a lender. The Note was due on August 3, 2021, is currently in default, and carries an interest rate of 8% per annum. The Note is due and payable in full unless converted partially or in its entirety upon the election of the lender into fully paid and non-assessable shares of common stock of the Company at a conversion rate of $7.00 per share. The Company did not recognize a beneficial conversion feature or debt discount as the conversion price was higher than the market price at the time of issuance of the note. Interest expense for the six months ended June 30, 2024 and 2023 totaled $597 and $595, respectively, resulting in accrued interest at June 30, 2024 and December 31, 2023 of $4,690 and $4,093. Principal balance on the note at June 30, 2024 and December 31, 2023 was $15,000.

EQUITY TRANSACTIONS

EQUITY TRANSACTIONS	6 Months Ended
	Jun. 30, 2024
EQUITY TRANSACTIONS
EQUITY TRANSACTIONS	NOTE 5 – EQUITY TRANSACTIONS The Company is authorized to issue 250,000,000 shares of common stock. There were no equity transactions during the six months ended June 30, 2024 or 2023, resulting in 1,135,194 shares of common stock issued and outstanding at June 30, 2024 and December 31, 2023.

GOING CONCERN

GOING CONCERN	6 Months Ended
	Jun. 30, 2024
GOING CONCERN
GOING CONCERN	NOTE 6 – GOING CONCERN The accompanying unaudited condensed financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. However, the Company has incurred losses since its inception totaling $1,353,464 and has no on-going operations. These factors raise substantial doubt about the ability of the Company to continue as a going concern. In this regard, management is proposing to raise any necessary additional funds not provided by operations through loans, additional sales of its common stock, or through a possible business combination. There is no assurance that the Company will be successful in raising this additional capital or in achieving profitable operations. The financial statements do not include any adjustments that might result from the outcome of these uncertainties.

LOSS PER SHARE

LOSS PER SHARE	6 Months Ended
	Jun. 30, 2024
LOSS PER SHARE
LOSS PER SHARE	NOTE 7 – LOSS PER SHARE The computation of basic loss per share is based on the weighted average number of shares outstanding during each period. The following data show the amounts used in computing loss per share for the six months ended: June 30, 2024 June 30, 2023 Net loss (numerator) $ (75,585 ) $ (50,446 ) Weighted average shares outstanding (denominator) 1,135,194 1,135,194 Basic and fully diluted net loss per share amount $ (0.07 ) $ (0.04 ) The computation of diluted earnings per common share is based on the weighted average number of shares outstanding during the year plus the common stock equivalents as detailed in the following chart. For the six months ended June 30, 2024 and 2023, the inclusion of these shares on the statements of operations would have resulted in a weighted average shares fully diluted number that was anti-dilutive, and as such they are excluded. The following data show the fully diluted shares for the six months ended June 30, 2024 and 2023: June 30, 2024 2023 Basic weighted average shares outstanding 1,135,194 1,135,194 Convertible debt 15,351 14,694 Total 1,150,545 1,149,888

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	6 Months Ended
	Jun. 30, 2024
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 8 – SUBSEQUENT EVENTS On July 1, 2024 the Company filed with the State of Nevada for the designation of 6,000,000 shares of Series A Preferred Stock (“Series A”) with a par value of $0.01 per share. Each share of Series A has liquidation priority over any Junior Securities, is convertible into common stock at the option of the holder on a ten-for-one basis and carries no common votes unless and until converted to common stock at which time the converted shares are entitled to vote on any matter submitted to common stockholders. The Series A shares are not entitled to dividends unless and until converted to common stock at which time they would have dividend rights as common stock holders. On July 25, 2024 the Board of Directors voted to issue a total of 620,000 shares of Series A Preferred Stock, valued at approximately $3.56 per share, to eight individuals and entities.

LOSS PER SHARE (Tables)

LOSS PER SHARE (Tables)	6 Months Ended
	Jun. 30, 2024
LOSS PER SHARE
Schedule of earnings per share	June 30, 2024 June 30, 2023 Net loss (numerator) $ (75,585 ) $ (50,446 ) Weighted average shares outstanding (denominator) 1,135,194 1,135,194 Basic and fully diluted net loss per share amount $ (0.07 ) $ (0.04 )
Schedule of fully diluted shares	June 30, 2024 2023 Basic weighted average shares outstanding 1,135,194 1,135,194 Convertible debt 15,351 14,694 Total 1,150,545 1,149,888

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended		6 Months Ended
	Dec. 31, 2023	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Mar. 08, 2018	Dec. 12, 2017
Interest expense, operating and nonoperating		$ 12,953	$ 11,998	$ 25,385	$ 23,607
Proceeds from related party debt				18,950	12,600
Director [Member]
Due to Related Parties, Current and Non Current	$ 14,500	15,000		15,000
Operating Leases, Rent Expense				3,000	3,000
Newly Affiliated Party [Member]
Debt instrument, face amount						$ 43,250
Debt instrument, interest rate, stated percentage						10%
Interest expense, operating and nonoperating				2,151	2,145
Accrued interest	25,156	27,307		27,307
Long-term debt, gross	43,250	43,250		43,250
Sole Officer And Director [Member]
Due to Related Parties, Current and Non Current	204,484	$ 223,434		$ 223,434
Debt instrument, face amount							$ 107,000
Debt instrument, interest rate, stated percentage		12%		12%
Interest expense, operating and nonoperating				$ 12,711	11,148
Accrued interest	73,250	$ 80,961		80,961
Proceeds from related party debt	118,170			18,950	$ 12,600
Repayments of related party debt	$ 20,686
Repayment of notes receivable from related parties				$ 5,000

NOTES PAYABLE (Details Narrativ

NOTES PAYABLE (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Jun. 25, 2024	Jun. 21, 2024	May 09, 2024	Dec. 31, 2023	Apr. 18, 2022	May 01, 2020	Jan. 23, 2019	Dec. 31, 2018	Nov. 15, 2018	Aug. 15, 2018	Jun. 14, 2016
Interest Expense, Operating and Nonoperating	$ 12,953	$ 11,998	$ 25,385	$ 23,607
Promissory Note 1
Debt Instrument, Face Amount															$ 35,000
Debt Instrument, Interest Rate, Stated Percentage															8%
Interest Expense, Operating and Nonoperating			1,392	1,388
Interest Payable, Current	22,534		22,534					$ 21,142
Long Term Debt, Gross	35,000		35,000					35,000
Promissory Note 2
Debt Instrument, Face Amount														$ 10,000
Debt Instrument, Interest Rate, Stated Percentage														12%
Interest Expense, Operating and Nonoperating			597	595
Interest Payable, Current	6,304		6,304					5,707
Long Term Debt, Gross	10,000		10,000					10,000
Promissory Note 3
Debt Instrument, Face Amount													$ 20,000
Debt Instrument, Interest Rate, Stated Percentage													12%
Interest Expense, Operating and Nonoperating			1,193	1,190
Interest Payable, Current	12,608		12,608					11,415
Long Term Debt, Gross	20,000		20,000					20,000
Promissory Note 4
Debt Instrument, Face Amount												$ 30,000
Debt Instrument, Interest Rate, Stated Percentage												12%
Interest Expense, Operating and Nonoperating			1,790	1,785
Interest Payable, Current	18,912		18,912					17,122
Long Term Debt, Gross	30,000		30,000					30,000
Promissory Note 5
Debt Instrument, Face Amount											$ 50,000
Debt Instrument, Interest Rate, Stated Percentage											12%
Interest Expense, Operating and Nonoperating			2,984	2,975
Interest Payable, Current	31,521		31,521					28,537
Long Term Debt, Gross	50,000		50,000					50,000
Promissory Note 6
Debt Instrument, Face Amount										$ 5,000
Debt Instrument, Interest Rate, Stated Percentage										12%
Interest Expense, Operating and Nonoperating			298	298
Interest Payable, Current	2,490		2,490					2,191
Long Term Debt, Gross	5,000		5,000					5,000
Promissory Note 8
Debt Instrument, Face Amount							$ 10,000
Debt Instrument, Interest Rate, Stated Percentage							10%
Interest Expense, Operating and Nonoperating			142	0
Interest Payable, Current	142		142					0
Long Term Debt, Gross	10,000		10,000					10,000
Promissory Note 9
Debt Instrument, Face Amount						$ 10,000
Debt Instrument, Interest Rate, Stated Percentage						10%
Interest Expense, Operating and Nonoperating			25	0
Interest Payable, Current	25		25					0
Long Term Debt, Gross	10,000		10,000					10,000
Promissory Note 10
Debt Instrument, Face Amount					$ 10,000
Debt Instrument, Interest Rate, Stated Percentage					10%
Interest Expense, Operating and Nonoperating			14	0
Interest Payable, Current	14		14					0
Long Term Debt, Gross	10,000		10,000					10,000
Promissory Note 7
Debt Instrument, Face Amount									$ 10,000
Debt Instrument, Interest Rate, Stated Percentage									8%
Interest Expense, Operating and Nonoperating			398	$ 397
Interest Payable, Current	1,761		1,761					1,363
Long Term Debt, Gross	$ 10,000		$ 10,000					$ 10,000

CONVERTIBLE NOTES PAYABLE (Deta

CONVERTIBLE NOTES PAYABLE (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Interest Expense, Operating and Nonoperating	$ 12,953	$ 11,998	$ 25,385	$ 23,607
A Lender
Debt Instrument, Face Amount	10,000		$ 10,000
Debt Instrument, Payment Terms			The Note was due on June 18, 2020, is currently in default, and carries an interest rate of 8% per annum
Debt Instrument, Convertible, Terms of Conversion Feature			The Note is due and payable in full unless converted partially or in its entirety upon the election of the lender into fully paid and non-assessable shares of common stock of the Company at a conversion rate of $2.00 per share
Debt Instrument, Unamortized Discount	4,000		$ 4,000
Debt Instrument, Unamortized Discount, Current	0		0		$ 0
Amortization of Debt Discount Premium			0	0
Interest Expense, Operating and Nonoperating			597	595
Long Term Debt, Gross	10,000		10,000		10,000
Interest Payable, Current	3,827		3,827		3,231
A Lender (2)
Debt Instrument, Face Amount	10,000		$ 10,000
Debt Instrument, Payment Terms			The Note was due on June 9, 2021, is currently in default, and carries an interest rate of 10% per annum
Debt Instrument, Convertible, Terms of Conversion Feature			The Note is due and payable in full unless converted partially or in its entirety upon the election of the lender into fully paid and non-assessable shares of common stock of the Company at a conversion rate of $2.50 per share
Debt Instrument, Unamortized Discount	6,200		$ 6,200
Debt Instrument, Unamortized Discount, Current	0		0		0
Amortization of Debt Discount Premium			0	0
Interest Expense, Operating and Nonoperating			497	496
Long Term Debt, Gross	10,000		10,000		10,000
Interest Payable, Current	4,059		4,059		3,562
A Lender (3)
Debt Instrument, Face Amount	15,000		$ 15,000
Debt Instrument, Payment Terms			The Note was due on August 3, 2021, is currently in default, and carries an interest rate of 8% per annum
Debt Instrument, Convertible, Terms of Conversion Feature			The Note is due and payable in full unless converted partially or in its entirety upon the election of the lender into fully paid and non-assessable shares of common stock of the Company at a conversion rate of $7.00 per share
Interest Expense, Operating and Nonoperating			$ 597	$ 595
Long Term Debt, Gross	15,000		15,000		15,000
Interest Payable, Current	$ 4,690		$ 4,690		$ 4,093

EQUITY TRANSACTIONS (Details Na

EQUITY TRANSACTIONS (Details Narrative) - shares	Jun. 30, 2024	Dec. 31, 2023
EQUITY TRANSACTIONS
Common Stock, Shares Authorized	250,000,000	250,000,000
Common Stock, Shares, Issued	1,135,194	1,135,194
Common Stock, Shares, Outstanding	1,135,194	1,135,194

GOING CONCERN (Details Narrativ

GOING CONCERN (Details Narrative) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
GOING CONCERN
Accumulated deficit	$ (1,353,464)	$ (1,277,879)

LOSS PER SHARE (Details)

LOSS PER SHARE (Details) - USD ($)	3 Months Ended				6 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2024	Jun. 30, 2023
LOSS PER SHARE
Net loss (numerator)	$ (35,932)	$ (39,653)	$ (26,810)	$ (23,636)	$ (75,585)	$ (50,446)
Weighted average shares outstanding (denominator)	1,135,194		1,135,194		1,135,194	1,135,194
Basic and fully diluted net loss per share amount	$ (0.03)		$ (0.02)		$ (0.07)	$ (0.04)

LOSS PER SHARE (Details 1)

LOSS PER SHARE (Details 1) - shares	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
LOSS PER SHARE
Basic weighted average shares outstanding	1,135,194	1,135,194	1,135,194	1,135,194
Convertible debt			15,351	14,694
Total			1,150,545	1,149,888

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - $ / shares	Jul. 25, 2024	Jul. 01, 2024	Jun. 30, 2024	Dec. 31, 2023
Preferred shares issued			0	0
Preferred shares par value			$ 0.01	$ 0.01
Series A Preferred Stock [Member] | Subsequent Event [Member]
Preferred shares issued	620,000	6,000,000
Preferred shares par value	$ 3.56	$ 0.01